A retrospective study comparing efficacy of treatment with imatinib alone and imatinib followed by surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors.
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2016
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 07 Jul 2016 New trial record